Comparison of anticancer effects of a novel histone deacetylase (HDAC) inhibitor CG200745 and SAHA in non-small lung cancer cells

被引：0
|
作者：
Kim, Hak-Ryul [1 ]
Jung, Jae-Wan [1 ]
Hwang, Ki-Eun [1 ]
Park, Chul [1 ]
Jeong, Eun-Taik [1 ]
机构：
[1] Wonwang Univ Hosp, Iksan, South Korea
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Lung cancer; Experimental approaches;
D O I：
10.1183/13993003.congress-2019.OA1911
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA1911
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Epigenetic Modulation with HDAC Inhibitor CG200745 Induces Anti-Proliferation in Non-Small Cell Lung Cancer Cells
    Chun, Sung-Min
    Lee, Ji-Young
    Choi, Jene
    Lee, Je-Hwan
    Hwang, Jung Jin
    Kim, Chung-Soo
    Suh, Young-Ah
    Jang, Se Jin
    PLOS ONE, 2015, 10 (03):
  • [2] Novel HDAC Inhibitor CG200745 Inhibit EMT and Induce Apoptosis in Lung Cancer Cells
    Kim, H. -R.
    Jung, J. W.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S451 - S451
  • [3] Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells
    Eun-Taex Oh
    Moon-Taek Park
    Bo-Hwa Choi
    Seonggu Ro
    Eun-Kyung Choi
    Seong-Yun Jeong
    Heon Joo Park
    Investigational New Drugs, 2012, 30 : 435 - 442
  • [4] Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells
    Oh, Eun-Taex
    Park, Moon-Taek
    Choi, Bo-Hwa
    Ro, Seonggu
    Choi, Eun-Kyung
    Jeong, Seong-Yun
    Park, Heon Joo
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 435 - 442
  • [5] A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL
    Jung Jin Hwang
    Yong Sook Kim
    Taelim Kim
    Mi Joung Kim
    In Gab Jeong
    Je-Hwan Lee
    Jene Choi
    Sejin Jang
    Seonggu Ro
    Choung-Soo Kim
    Investigational New Drugs, 2012, 30 : 1434 - 1442
  • [6] A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL
    Hwang, Jung Jin
    Kim, Yong Sook
    Kim, Taelim
    Kim, Mi Joung
    Jeong, In Gab
    Lee, Je-Hwan
    Choi, Jene
    Jang, Sejin
    Ro, Seonggu
    Kim, Choung-Soo
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1434 - 1442
  • [7] A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance
    Lee, Hee Seung
    Park, Soo Been
    Kim, Sun A.
    Kwon, Sool Ki
    Cha, Hyunju
    Lee, Do Young
    Ro, Seonggu
    Cho, Joong Myung
    Song, Si Young
    SCIENTIFIC REPORTS, 2017, 7
  • [8] A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance
    Hee Seung Lee
    Soo Been Park
    Sun A Kim
    Sool Ki Kwon
    Hyunju Cha
    Do Young Lee
    Seonggu Ro
    Joong Myung Cho
    Si Young Song
    Scientific Reports, 7
  • [9] Correction to: A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL
    Jung Jin Hwang
    Yong Sook Kim
    Taelim Kim
    Mi Joung Kim
    In Gab Jeong
    Je-Hwan Lee
    Jene Choi
    Sejin Jang
    Seonggu Ro
    Choung-Soo Kim
    Investigational New Drugs, 2019, 37 : 796 - 796
  • [10] Phase I clinical, pharmacokinetic, and pharmacodynamic study of CG200745, a histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumors.
    Kim, Kyu-Pyo
    Hong, Yong Sang
    Ahn, Jin-Hee
    Lee, Jae-Lyun
    Bae, Kyun-Seop
    Kim, Tae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345